Molecular Pharmaceutics · 2013 · 48 citations · 34 references
PharmacyBiotechnologyPharmaceuticsDrug DeliveryMolecular VirologyVaccinologyNucleic Acid DeliveryNucleic Acid VaccinesVaccine DeliveryVaccine Delivery SystemsVaccine PlatformsViral VaccinesBovine Serum AlbuminNanoparticle Vaccine FormulationsParticle-protein InteractionsPrint TechnologyReplicon VaccineRna Delivery NanoparticlesRna Delivery SystemsVirus-like Particle Engineering
Herein we report the development of a nonviral lipid-complexed PRINT (particle replication in nonwetting templates) protein particle system (LPP particle) for RNA replicon delivery with a view toward RNA replicon-based vaccination. Cylindrical bovine serum albumin (BSA) particles (diameter (d) 1 μm, height (h) 1 μm) loaded with RNA replicon and stabilized with a fully reversible disulfide cross-linker were fabricated using PRINT technology. Highly efficient delivery of the particles to Vero cells was achieved by complexing particles with a mixture of 1,2-dioleoyl-3-trimethylammonium-propane (DOTAP) and 1,2-dioleoyl-sn-glycero-3-phosphoethanolamine (DOPE) lipids. Our data suggest that (1) this lipid-complexed protein particle is a promising system for delivery of RNA replicon-based vaccines and (2) it is necessary to use a degradable cross-linker for successful delivery of RNA replicon via protein-based particles.
34
Direct Gene Transfer into Mouse Muscle in Vivo
Jon A. Wolff, Robert W. Malone, Phillip Williams et al. · Science · 1990 · 4.2K citations
Nonviral delivery of self-amplifying RNA vaccines
Andrew J. Geall, Ayush Verma, Gillis R. Otten et al. · Proceedings of the National Academy of Sciences · 2012 · 667 citations · Full text